Alterity Therapeutics (ATHE) Short-term Investments (2017 - 2025)

Alterity Therapeutics has reported Short-term Investments for 5 years, with the latest figure at $26779.7 in Q2 2025.

• For the quarter ending Q2 2025, Short-term Investments changed 0.08% year-over-year to $26779.7; the trailing twelve-month figure through Jun 2025 stood at $26779.7 (changed 0.08% YoY), and the FY2025 full-year result was $26779.7, changed 0.08% from the prior year.
• Short-term Investments for Q2 2025 stood at $26779.7, roughly flat from $26801.2 in the prior quarter.
• The five-year high for Short-term Investments was $26801.2 in Q2 2024, with the low at $7328.9 in Q2 2022.
• Average Short-term Investments over 4 years is $21871.6, with a median of $26678.2 recorded in 2025.
• Year-over-year, Short-term Investments surged 262.63% in 2023 and declined 0.08% in 2025.
• Tracing ATHE's Short-term Investments over 4 years: stood at $7328.9 in 2022, then surged by 262.63% to $26576.7 in 2023, then increased by 0.84% to $26801.2 in 2024, then slipped by 0.08% to $26779.7 in 2025.
• The last three Short-term Investments figures came in at $26779.7 (Q2 2025), $26801.2 (Q2 2024), and $26576.7 (Q2 2023), per Business Quant data.

Peer Comparison